FDA considers warning about antidepressants during pregnancy

FDA considers warning about antidepressants during pregnancy

An advisory panel has urged the Federal Drug Administration to warn against the use of antidepressants in pregnant women, proposing a label change for this type of medication.

What I learned by going off SSRIs after nearly a decade

STAT’s Sarah Todd happened to go off escitalopram amid new public scrutiny of antidepressants. Here’s what she found.

Kennedy’s mental health drug skepticism lands at FDA panel

WASHINGTON — The Food and Drug Administration, making good on a Trump administration promise to examine usage of antidepressants, on Monday convened a panel largely of antidepressant skeptics to discuss the health impacts of taking such medicine while pregnant, though…

FDA panel on the use of antidepressants during pregnancy is alarming experts

By Corinne Purtill, Los Angeles Times LOS ANGELES — The U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a class of antidepressant drugs long criticized by Health and Human Services Secretary Robert F. Kennedy Jr. On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications like fluoxetine (Prozac), sertraline (Zoloft) and citalopr…

Kennedy's mental health drug skepticism lands at FDA panel

The Food and Drug Administration, making good on a Trump administration promise to examine usage of antidepressants, on Monday convened a panel largely of antidepressant skeptics to discuss the health impacts of taking such medicine while pregnant, though several panelists have no particular expertise on pregnancy research. The panelists during the two-hour event essentially echoed the statements of Health and Human Services Secretary Robert F. …

FDA Expert Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy

An FDA expert roundtable on Selective Serotonin Reuptake Inhibitors (SSRIs) and pregnancy to facilitate discussions on the safety of the developing child. Held on July 21, 2025 and featuring, amongst others, David Healy, Adam Urato, Joanna Moncrieff, Josef Witt-Doerring and Roger McFillin. The post FDA Expert Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy appeared first on Mad In America.